Conference Coverage

EULAR scientific program highlights spectrum of translational research


 


Also on Wednesday, a session will tackle the relationship between psychological distress and pain in immune-mediated disease. “Pain is the major symptom of rheumatic diseases, and the role of the psyche remains poorly understood,” Dr. Landewé said. “But we know one thing for sure: There is an association, and speakers from outside the field of rheumatology will help explain.”

Attendees at this bench-to-bedside session will learn how distress appears to exacerbate arthritis pain and how managing psychological stress can help optimize outcomes in arthritis pain. Experts also will describe research on integrated brain pathways in pain and distress, as well as risk factors for cognitive impairment in RA.

Thursday, June 14

Prof. Thomas Dörner, professor of rheumatology at Charite Universitätsmedizin, Berlin

Prof. Thomas Dörner

On Thursday, a clinical science session on reproductive issues in rheumatology reflects the fundamental shift in outlook for many of these patients. “As care has improved in the past decades, reproductive matters have arisen,” said Dr. Dörner. “Especially in patients with systemic autoimmune diseases; these are often challenging. The session will address recent insights and practical approaches based on new scientific data.”

Topics in this session will include the use of estrogens and other hormonal therapies in patients with rheumatic disease, registry studies of rheumatologic conditions during pregnancy, and how clinicians can best discuss sexual concerns with their rheumatology patients.

Pages

Recommended Reading

ACR sounds more welcoming tone in new biosimilars position paper
Psoriatic Arthritis ICYMI
Experts review the year in rheumatology ... and what lies ahead
Psoriatic Arthritis ICYMI
Xeljanz: FDA panel recommends ulcerative colitis indication
Psoriatic Arthritis ICYMI
Arthritis limits physical activity the most in the South
Psoriatic Arthritis ICYMI
FDA approves certolizumab label update for pregnancy, breastfeeding
Psoriatic Arthritis ICYMI
TB in 2017: Good news and bad news
Psoriatic Arthritis ICYMI
Reassurance for women taking certolizumab during pregnancy
Psoriatic Arthritis ICYMI
AbbVie, Samsung Bioepis settle suits with delayed U.S. entry for adalimumab biosimilar
Psoriatic Arthritis ICYMI
MACE risk similar across arthritis subtypes
Psoriatic Arthritis ICYMI
Methotrexate-induced pulmonary fibrosis risk examined in 10-year study
Psoriatic Arthritis ICYMI